Search

Your search keyword '"Nomiyama, Takashi"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Nomiyama, Takashi" Remove constraint Author: "Nomiyama, Takashi"
305 results on '"Nomiyama, Takashi"'

Search Results

2. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

12. Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial

14. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

16. Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy

19. Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial

22. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice

26. Responsiveness of insulin-induced cardiac sympathetic nerve activation associates with blood pressure regulation in diabetics

27. Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus

28. Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression

30. SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation

31. Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial

41. 頭蓋咽頭腫の長期治療経過に伴う汎下垂体機能低下症により肝硬変症をきたしたと考えられる一例

42. Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice

Catalog

Books, media, physical & digital resources